|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 401 Ninth Street NW, Suite 900 |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 27057-12
|
||||||||
|
6. House ID# 302500000
|
TYPE OF REPORT | 8. Year | 2018 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Beth Feldpush |
Date | 10/19/2018 12:13:13 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Issues pertaining to Medicaid reform, block grant proposals, per capita caps
Medicare and Medicaid Graduate Medical Education
Medicaid provider taxes
Medicare bad debt payments
Medicaid Waivers
Medicaid Expansion Issues
Medicaid Disproportionate Share Hospital Payments
Medicare Disproportionate Share Hospital Payments
Meaningful use Stage 2 and 3
Legislation related to chronic care treatment
Legislation related to Medicare reimbursement for telehealth service
Medicaid managed care policies rulemaking
Medicaid supplemental payments to hospitals
Medicare site neutral payments for hospital outpatient departments
Legislation related to health care disparities
Medicaid- State flexibility
Medicaid 1115 & 1332 Waivers
Upper Payment Limit payments
State Financing of Medicaid
Medicare Part B Cuts-OPPS proposed rule to 340 B covered entities
Medicaid Pediatric Health Homes
Hospital Price Transparency
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Beth |
Feldpush |
|
|
|
Amanda |
Walsh |
|
|
|
Jocelyn |
Wiles |
|
|
|
Carlos |
Jackson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Repeal of the Affordable Care Act
H.R. 1628 The American Health Care Act
Development of legislation to protect essential hospitals
Issues related to telehealth
Mental Health
Essential Health Benefits created by the Affordable Care Act
Access to hospital emergency services
Issues related to the 340B Drug Pricing Program
HR1628 Better Care Reconciliation Act
ACA Cost Sharing Reduction Subsidies
Graham-Cassidy Amendment to HR 1628
340B drug pricing program
HR3545-Overdose, Prevention and Patient Advocacy Act
HR4392 CMS OPPS 340b rule moratorium
HR4710 340b PAUSE Act
Bipartisan Healthcare Stabilization Act of 2017
Opioid Crisis Response Act of 2018
42 CFR Part 2
IMD Exclusion
Prescription drug monitoring programs
H.R. 5197, S. 2516, Alternatives to opioids in the emergency dept Act
H.R. 5102, Substance Use Disorder Workforce Loan Repayment Act
H.R. 5261, Treatment, Education, and Community Help to Combat Opioid Addiction Act
Poison Center Network Enhancement Act
A Bill to support the peer support specialist workforce
HR6 Support for Patients and Communities Act
H.R. 4710 PAUSE Act
HELP Act S. 2312
HR6378 Pandemic and All Hazards Preparedness and Advancing Innovation Act
S.974 CREATES Act
S.2843 Opioid Workforce Act
HEAL Act S.3120
SERV Communities Act H. R. 6071
S.428, H.R. 3325 The Advancing Care for Exceptional (ACE) Kids Act
Cassidy Surprise Billing Draft
H.R.6 Support for Patients and Communities Act
Protecting Patients from Surprise Medical Bills
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Beth |
Feldpush |
|
|
|
Amanda |
Walsh |
|
|
|
Jocelyn |
Wiles |
|
|
|
Carlos |
Jackson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Bipartisan Budget Act of 2015
White House FY 2018 Budget request
HR1 Tax cuts and Jobs Act
H.J. Res123 Continuing Resolution
H.R. 1892, The Bipartisan Budget Act of 2018 (Medicaid DSH)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Beth |
Feldpush |
|
|
|
Amanda |
Walsh |
|
|
|
Jocelyn |
Wiles |
|
|
|
Carlos |
Jackson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |